Sarepta Therapeutics, Inc. - 13 Aug 2025 SCHEDULE 13D/A Report for ARROWHEAD PHARMACEUTICALS, INC. Common stock, par value $0.001 per share (the "Common Stock") (ARWR)

Filing Manager: Sarepta Therapeutics, Inc.
Reporting Manager: Sarepta Therapeutics, Inc.
Security: ARROWHEAD PHARMACEUTICALS, INC. Common stock, par value $0.001 per share (the "Common Stock")
Symbol: ARWR
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Filing time: 15 Aug 2025, 17:28:19 UTC
Date of event: 13 Aug 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Sarepta Therapeutics, Inc.	0%	0	0	0	/s/ Ryan Wong	Ryan Wong, Executive Vice President, Chief Financial Officer	0000873303
Sarepta Therapeutics Investments, Inc.	0%	0	0	0	/s/ Joe Bratica	Joe Bratica, President